Picking Up the Pieces After Hwang
By Gretchen Vogel,
Science
| 04. 28. 2006
A year ago, it seemed so easy. In May 2005, Woo Suk Hwang and his colleagues told the world that they could make embryonic stem (ES) cells from cloned human embryos with an efficiency that astounded--and thrilled--their colleagues. In roughly one out of every 12 tries, the South Korean team reported, they could produce ES cell lines that were a genetic match to patients. Scientists hoped to use such cells to probe the genetic triggers of diseases such as diabetes and amyotrophic lateral sclerosis (ALS). Some dreamed of using them as the raw material for developing new tissues and cells that could treat previously incurable maladies.
A few months ago, those claims famously unraveled. It is now clear that Hwang's team does not have any ES cell lines created from patients. It is also clear that the group didn't fail for lack of trying: The team apparently used more than 2200 donated human oocytes in their experiments--more than five times the number they claimed in their papers (Science, 10 February, p. 754). The meltdown dashed the hopes of researchers and...
Related Articles
By Gilma Avalos, NBC | 07.03.2024
Image by Josh Appel from Unsplash
The dream of becoming parents is turning into a nightmare for hundreds of people caught up in a surrogacy money scandal.
Some of the individuals are facing infertility or medical challenges, seeing surrogacy as...
By Emma McDonald Kennedy
| 07.11.2024
Louise Perry’s recent article in The Spectator cautions against “The quiet return of eugenics,” a threat she locates in preimplantation genetic testing for polygenic disorders. The technology is billed as a way for parents undergoing IVF to select which embryo to implant based on information about each embryo’s genetic risk factors and traits. These reports, she says, give parents “a very full picture of the adult that embryo could become”––from their child’s risk of developing different diseases to their “likely...
By Sonia Suter and Naomi Cahn, PET | 07.01.2024
Image by Dusdn5959 from Wikimedia Commons
Since the US Supreme Court's 2022 decision to overturn Roe v Wade (see BioNews 1147), there have been worries about the future of IVF in the USA. Both abortion and IVF involve decisions...